M. I. Graham

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

R. Souhami, R. Souhami, A. Mclean, 2004, Cancer Chemotherapy and Pharmacology.

Potent, selective, water-soluble benzodiazepine-based CCKB receptor antagonists that contain lipophilic carboxylate surrogates

V. Matassa, S. Freedman, S. Fletcher, 1995 .

Mesna--a short review.

I. Shaw, M. I. Graham, 1987, Cancer treatment reviews.

2-Chloroacetaldehyde, a metabolite of cyclophosphamide in the rat.

A. Mclean, I. Shaw, M. I. Graham, 1983, Xenobiotica; the fate of foreign compounds in biological systems.

2-Chloroacetaldehyde: a metabolite of cyclophosphamide in the rat.

A. Mclean, I. Shaw, M. I. Graham, 1983, Cancer treatment reviews.

C5-piperazinyl-1,4-benzodiazepines, water-soluble, orally bioa vailable CCKB/gastrin receptor antagonists

V. Matassa, J. G. Neduvelil, S. Freedman, 1995 .

4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activity.

J. Metzger, D. Macintyre, C. Swain, 1998, Journal of medicinal chemistry.

Excretion of cyclophosphamide metabolites in bile.

I. Shaw, M. I. Graham, Ian C. Shaw, 1984, Biochemical pharmacology.

A Proposed Mechanism for Isophosphamide-induced Kidney Toxicity

M. I. Graham, I. Shaw, M. S. Weeks, 1985 .